TNF and ischemic stroke: The melanocortin MC4 receptor agonist RO27-3225 (used to reduce expression of TNF-α, BAX, ERK1/2, JNK1/2, and cascapse-3 and counteract prolonged/recurrent inflammatory and apoptotic responses) provides neuroprotective function and promotes functional recovery in ischemic stroke (63).